Clinical trial
CAR-T Cellular Therapy for B Cell Malignancies Involved in Central Nervous System
NCT04287309 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CAR-T Cellular Therapy for B Cell Malignancies Involved in Central Nervous System
- Lead sponsor
- Zhejiang University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 28, 2020
- Completion date
- February 28, 2023
- Enrollment
- 20 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hematological malignancy